FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

NCT03422510 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Focal Segmental Glomerulosclerosis

Interventions

DRUG: CXA-10

Sponsor

Complexa, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]